Buerger's disease epidemiology and demographics: Difference between revisions

Jump to navigation Jump to search
Aditya Govindavarjhulla (talk | contribs)
Maheep Sangha (talk | contribs)
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Buerger's disease}}
{{Buerger's disease}}
{{CMG}}
Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
Please help WikiDoc by adding more content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.


{{CMG}}
==Overview==
==Epidemiology and Demographics==
==Epidemiology and Demographics==


Line 23: Line 22:
{{WS}}
{{WS}}
[[Category:Needs content]]
[[Category:Needs content]]
[[Category:Cardiovascular diseases]]
[[Category:Angiology]]
[[Category:Cardiology]]
[[Category:Rheumatology]]

Revision as of 17:05, 1 March 2013

Buerger's disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Buerger's Disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Buerger's disease epidemiology and demographics On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Buerger's disease epidemiology and demographics

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Buerger's disease epidemiology and demographics

CDC on Buerger's disease epidemiology and demographics

Buerger's disease epidemiology and demographics in the news

Blogs on Buerger's disease epidemiology and demographics

Directions to Hospitals Treating Buerger's disease

Risk calculators and risk factors for Buerger's disease epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Please help WikiDoc by adding more content here. It's easy! Click here to learn about editing.

Epidemiology and Demographics

Age

  • The average age when symptoms begin is around 35 years.
  • Thromboangiitis obliterans mostly affects men ages 20 to 40 who have a history of heavy smoking or chewing tobacco.
  • This disorder is very uncommon in children, but it may occur in children with autoimmune diseases.

Gender

  • Buerger's is more common among men than women.
  • Woman and older adults are affected less often.
  • Only 1 out of 10 patients are women.

Prevalence

It is more common in Israel, Japan and India along the "old silk route" than in the United States and Europe. The disease is most common among South Asians, who often smoke cigarettes made of raw tobacco (bidis).

References

Template:WH Template:WS